文献速递鼻科

胃泌素释放肽参与小鼠过敏性鼻炎的发生

Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.
PubMed 文献 · Laryngoscope · 2018-08-27

该研究在小鼠过敏性鼻炎模型中检测胃泌素释放肽(GRP)及其受体GRPR的表达与定位,并用GRPR拮抗剂RC-3095干预,发现GRP-GRPR系统可能参与过敏性炎症,或为难治性过敏性鼻炎的新治疗靶点。

要点

  • GRP与GRPR在过敏性鼻炎小鼠鼻黏膜上皮及腺体周围间质高表达。
  • GRPR拮抗剂RC-3095可显著减少过敏性鼻炎小鼠的喷嚏和鼻摩擦。
  • RC-3095对组胺诱发的喷嚏也有抑制作用。

核心结论

  • GRP-GRPR系统可能参与过敏性炎症,或为难治性过敏性鼻炎的新治疗靶点。

研究设计与样本

  • 动物模型体内研究,在BALB/c小鼠中建立三种过敏性鼻炎模型。

主要发现

  • 免疫染色显示GRP和GRPR在过敏性鼻炎组鼻黏膜上皮及鼻腺周围间质高表达。
  • Western blotting显示鼻黏膜GRP和GRPR表达随鼻致敏程度增加而升高。
  • AR+RC-3095组治疗后平均喷嚏和鼻摩擦计数显著低于AR+鼻盐水组。
  • 鼻腺周围肥大细胞常与GRPR共定位。
  • RC-3095能有效减少组胺诱发的喷嚏。

临床怎么用

  • GRP-GRPR系统可作为过敏性鼻炎特别是难治性过敏性鼻炎的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gastrin-releasing peptide (GRP) is a neuropeptide that targets transmembrane-type receptors. Its role in allergic rhinitis (AR) has yet to be investigated. The present study utilized the nasal mucosa of AR model mice to examine GRP and GRP receptor (GRPR) expression levels, localization, and other factors to evaluate their role in AR pathology. STUDY DESIGN: In vivo study in an animal model. METHODS: GRP and GRPR expression levels were examined in three different AR models established in BALB/c mice. In addition, a GRPR antagonist (RC-3095) was administered to AR mice to investigate its effect. The distribution of GRPR expression on mast cells in the nasal mucosa with AR was examined. Finally, we investigated the inhibitory effect of RC-3095 on allergy symptoms induced by histamine. RESULTS: GRP and GRPR were highly expressed in the nasal mucosal epithelium and interstitial tissues surrounding the nasal glands in AR groups according to immunostaining. GRP and GRPR expression as determined by western blotting increased in the nasal mucosa as the degree of nasal sensitization increased. In addition, the average counts of sneezing and nasal rubbing after treatment in the AR + RC-3095 group were significantly lower than those in the AR + nasal saline group. Mast cells often colocalized with GRPR around nasal glands. Moreover, RC-3095 was effective in reducing sneezing induced by histamine. CONCLUSION: The GRP-GRPR system is likely to be involved in allergic inflammation. This system may represent a novel therapeutic target for refractory AR. LEVEL OF EVIDENCE: NA. Laryngoscope, E377-E384, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Matsumoto Y, Yokoi H, Kimura T, et al. Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice. Laryngoscope. 2018. PMID: 30151920. doi:10.1002/lary.27394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。